Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28760238 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL28485740 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL6159782 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL8423278 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL8421983 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL11233672 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL22157373 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL22157437 | 0.98 | TSHR (0.42) | TSHRALDH1A1DNM1KCNH2FAAH | |
| Hydrochloric Acid SCHEMBL22771836 | 0.98 | TSHR (0.42) | TSHRALDH1A1DNM1KCNH2FAAH | |
| SCHEMBL2156532 | 0.98 | TSHR (0.48) | TSHRALDH1A1DNM1KCNH2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2861670-B1 | METAL FREE REACTIVE DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2017-08-16 | — | — | EP | claimed |
| EP-3039083-B1 | DYE MIXTURES OF METAL-FREE REACTIVE DYES, PRODUCTION AND USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2017-06-07 | — | — | EP | claimed |
| EP-3884019-B1 | HOME CARE COMPOSITIONS | COLGATE PALMOLIVE CO (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-3884019-A1 | HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-29 | — | — | EP | disclosed |
| CN-113227340-A | Home care compositions | 高露洁-棕榄公司 | 2021-08-06 | — | — | CN | disclosed |
| US-11008533-B2 | Home care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2021-05-18 | — | — | US | disclosed |
| WO-2020139335-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | WO | disclosed |
| US-20200208081-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | US | disclosed |
| CN-110981786-A | 2-arylvinyl-cyclic amine derivative and preparation method and application thereof | 泰州医药城国科化物生物医药科技有限公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-110981787-A | 2- (2, 2-diaryl vinyl) -quaternary ammonium salt type cyclic amine derivative and preparation method thereof | 泰州医药城国科化物生物医药科技有限公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-110240559-A | 2-(2,2- diarylethene base) Cycloamine derivative and preparation method thereof | 泰州医药城国科化物生物医药科技有限公司 | 2019-09-17 | — | — | CN | disclosed |
| US-7196111-B2 | Pyrazolo[1,5a]pyrimidine compounds as antiviral agents | SCHERING CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |
| US-7157198-B2 | Toner for electrostatic latent image development and an image forming method | KONICA MINOLTA HOLDINGS, INC (JP) | 2007-01-02 | — | — | US | disclosed |
| US-20060094706-A1 | Pyrazolopyrimidines as protein kinase inhibitors | SCHERING CORPORATION | 2006-05-04 | — | — | US | disclosed |
| US-20050214665-A1 | Toner for electrostatic latent image development and an image forming method | KONICA MINOLTA HOLDINGS, INC. (JP) | 2005-09-29 | — | — | US | disclosed |
| EP-1511751-A1 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS | Neogenesis Pharmaceuticals, Inc. (US) | 2005-03-09 | — | — | EP | disclosed |
| US-20040038993-A1 | Pyrazolo[1,5a]pyrimidine compounds as antiviral agents | NEOGENESIS PHARMACEUTICALS, INC. | 2004-02-26 | — | — | US | disclosed |
| WO-2003101993-A1 | PYRAZOLO` 1,5A! PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS | NEOGENESIS PHARMACEUTICALS, INC. (US) | 2003-12-11 | — | — | WO | disclosed |
| US-20030194629-A1 | Production apparatus of toner for developing electrostatic images, production method thereof, and toner for developing electrostatic images | KONICA CORPORATION (JP) | 2003-10-16 | — | — | US | disclosed |
| US-5760091-A | ADDING TO SEAWATER SYSTEM AN AMINE COMPOUND AND A POLYAMINE COMPOUND | KATAYAMA CHEMICAL, INC. (JP) | 1998-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038993-A1 | Pyrazolo[1,5a]pyrimidine compounds as antiviral agents | RNGTT, PNP, ZC3HAV1 | TSHR 4412/4885ALDH1A1 482/4885DNM1 1976/4885 |
| US-20060094706-A1 | Pyrazolopyrimidines as protein kinase inhibitors | CDKN1A, EIF2AK2, DCK | TSHR 4206/4885ALDH1A1 1771/4885DNM1 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.